Identifying effective intervention components for smoking cessation: A factorial screening experiment

Addiction

Volumn 111, Issue 1, 2016, Pages 129-141

  Piper, Megan E ^a   Fiore, Michael C ^a   Smith, Stevens S ^a   Fraser, David ^a   Bolt, Daniel M ^b   Collins, Linda M ^c   Mermelstein, Robin ^d   Schlam, Tanya R ^a   Cook, Jessica W ^a,e   Jorenby, Douglas E ^a   Loh, Wei Yin ^f   Baker, Timothy B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^f University of Wisconsin Madison   (United States)

Author keywords

Chronic care smoking treatment; Comparative effectiveness; Factorial experiment; Multiphase Optimization Strategy (MOST); Nicotine replacement therapy; Phase Based Model of smoking treatment; Primary care; Smoking cessation; Tobacco dependence

Indexed keywords

NICOTINE GUM;

CONTROLLED STUDY; COUNSELING; FEMALE; HUMAN; MALE; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TOBACCO USE DISORDER; TREATMENT OUTCOME; WISCONSIN;

COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; WISCONSIN;

EID: 84997428367     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13162     Document Type: Article

References (71)

1. US Department of Health and Human Services (USDHHS) The Health Consequences Of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: USDHHS; 2014.
2. Fiore M. C., Jaen C. R., Baker T. B., Bailey W. C., Benowitz N., Curry S. J., et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, US Public Health Service; 2008.
3. Fiore M. C., Bailey W. C., Cohen S. J. Smoking Cessation: Clinical Practice Guideline No. 18. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996.
4. Niaura R., Abrams D. B. Smoking cessation: progress, priorities, and prospectus. J Consult Clin Psychol 2002; 70: 494-509.
5. Piasecki T. M., Baker T. B. Any further progress in smoking cessation treatment? Nicotine Tob Res 2001; 3: 311-23.
6. Stead L. F., Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2012; 1CD009670.
7. Collins L. M., Murphy S. A., Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. Am J Prev Med 2007; 32: S112-8.
8. Collins L. M., Baker T. B., Mermelstein R. J., Piper M. E., Jorenby D. E., Smith S. S., et al. The Multiphase Optimization Strategy for engineering effective tobacco use interventions. Ann Behav Med 2011; 41: 208-26.
9. Collins L. M., Murphy S. A., Nair V. N., Strecher V. J. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med 2005; 30: 65-73.
10. Collins L. M., Dziak J. J., Kugler K. C., Trail J. B. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med 2014; 47: 498-504.
11. Baker T. B., Collins L. M., Mermelstein R., Piper M. E., Schlam T. R., Cook J. W. et al. Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction 2016; 111: 107-16.
12. Cook J. W., Baker T. B., Fiore M. C., Smith S. S., Fraser D., Bolt D. M. et al. Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment. Addiction 2016; 111: 117-28.
13. Schlam T. R., Fiore M. C., Smith S. S., Fraser D., Bolt D. M., Collins L. M. et al. Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment. Addiction 2016; 111: 142-55.
14. Baker T. B., Mermelstein R., Collins L. M., Piper M. E., Jorenby D. E., Smith S. S., et al. New methods for tobacco dependence treatment research. Ann Behav Med 2011; 41: 192-207.
15. Schlam T. R., Baker T. B. Interventions for tobacco smoking. Annu Rev Clin Psychol 2013; 9: 675-702.
16. Kenford S. L., Fiore M. C., Jorenby D. E., Smith S. S., Wetter D., Baker T. B. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 1994; 271: 589-94.
17. Piasecki T. M., Fiore M. C., Baker T. B. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol 1998; 107: 238-51.
18. Hughes J. R. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res 2007; 9: 329-39.
19. Jorenby D. E., Hatsukami D. K., Smith S. S., Fiore M. C., Allen S., Jensen J., et al. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) 1996; 128: 130-8.
20. Tonstad S., Tonnesen P., Hajek P., Williams K. E., Billing C. B., Reeves K. R. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006; 296: 64-71.
21. Stapleton J. A., Russell M. A., Feyerabend C., Wiseman S. M., Gustavsson G., Sawe U., et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995; 90: 31-42.
22. Gwaltney C. J., Metrik J., Kahler C. W., Shiffman S. Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav 2009; 23: 56-66.
23. Kirchner T. R., Shiffman S., Wileyto E. P. Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol 2012; 121: 187-97.
24. Piasecki T. M., Jorenby D. E., Smith S. S., Fiore M. C., Baker T. B. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol 2003; 112: 3-13.
25. Glasgow R. E., Orleans C. T., Wagner E. H. Does the chronic care model serve also as a template for improving prevention? Milbank Q 2001; 79: 579-612iv-v.
26. McLellan A., Lewis D. C., O'Brein C. P., Kleber H. D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689-95.
27. Riley W. T., Glasgow R. E., Etheredge L., Abernethy A. P. Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med 2013; 2: 10.
28. Rose J. E., Herskovic J. E., Behm F. M., Westman E. C. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 2009; 11: 1067-75.
29. Rose J. E., Behm F. M., Westman E. C., Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 2006; 8: 89-101.
30. Lindson N., Aveyard P. An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl) 2011; 214: 579-92.
31. Fiore M. C., Bailey W. C., Cohen S. J. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, US Public Health Service; 2000.
32. Shiffman S. Coping with temptations to smoke. J Consult Clin Psychol 1984; 52: 261-7.
33. Williams G. C., McGregor H. A., Sharp D., Levesque C., Kouides R. W., Ryan R. M., et al. Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 2006; 25: 91-101.
34. Williams G., Minicucci D., Kouides R., Levesque C., Chirkov V., Ryan R., et al. Self-determination, smoking, diet and health. Health Educ Res 2002; 17: 512-21.
35. Abrams D. B., Monti P. M., Carey K. B., Pinto R. P., Jacobus S. I. Reactivity to smoking cues and relapse: Two studies of discriminant validity. Behav Res Ther 1988; 26: 225-33.
36. Droungas A., Ehrman R. N., Childress A. R., O'Brien C. P. Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav 1995; 20: 657-73.
37. Juliano L. M., Brandon T. H. Reactivity to instructed smoking availability and environmental cues: evidence with urge and reaction time. Exp Clin Psychopharmacol 1998; 6: 45-53.
38. Juliano L. M., Brandon T. H. Effects of nicotine dose, instructional set, and outcome expectancies on the subjective effects of smoking in the presence of a stressor. J Abnorm Psychol 2002; 111: 88-97.
39. Hughes J. R., Carpenter M. J. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006; 8: 739-49.
40. Cinciripini P. M., Lapitsky L., Seay S., Wallfisch A., Kitchens K., Van Vunakis H. The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol 1995; 63: 388-99.
41. Cinciripini P. M., Wetter D. W., McClure J. B. Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict Behav 1997; 22: 759-67.
42. Farkas A. J. When does cigarette fading increase the likelihood of future cessation? Ann Behav Med 1999; 21: 71-6.
43. Baker T. B., Brandon T. H., Chassin L. Motivational influences on cigarette smoking. Annu Rev Psychol 2004; 55: 463-91.
44. McCarthy D. E., Piasecki T. M., Fiore M. C., Baker T. B. Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol 2006; 115: 454-66.
45. Brandon T. H., Tiffany S. T., Obremski K. M., Baker T. B. Postcessation cigarette use: the process of relapse. Addict Behav 1990; 15: 105-14.
46. Garvey A. J., Bliss R. E., Hitchcock J. L., Heinold J. W., Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 1992; 17: 367-77.
47. Shiffman S., Balabanis M. Do drinking and smoking go together? Alcohol Health Res World 1996; 20: 107-10.
48. Chaudhri N., Caggiula A. R., Donny E. C., Palmatier M. I., Liu X., Sved A. F. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 2006; 184: 353-66.
49. Kenny P. J., Markou A. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci 2005; 25: 6208-12.
50. Shiffman S., Scharf D. M., Shadel W. G., Gwaltney C. J., Dang Q., Paton S. M., et al. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol 2006; 74: 276-85.
51. Ferguson S. G., Gitchell J. G., Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction 2012; 107: 1349-53.
52. Japuntich S. J., Piper M. E., Leventhal A. M., Bolt D. M., Baker T. B. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. J Consult Clin Psychol 2011; 79: 34-42.
53. Cook J. W., Piper M. E., Leventhal A. M., Schlam T. R., Fiore M. C., Baker T. B. Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol 2015; 124: 215-25.
54. Cahill K., Stevens S., Perera R., Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013; 5CD009329:
55. Bolt D. M., Piper M. E., Theobald W. E., Baker T. B. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol 2012; 80: 54-65.
56. Bohadana A., Nilsson F., Rasmussen T., Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000; 160: 3128-34.
57. Sweeney C. T., Fant R. V., Fagerstrom K. O., McGovern J. F., Henningfield J. E. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 2001; 15: 453-67.
58. Fraser D., Christiansen B. A., Adsit R., Baker T. B., Fiore M. C. Electronic health records as a tool for recruitment of participants' clinical effectiveness research: lessons learned from tobacco cessation. Transl Behav Med 2013; 3: 244-52.
59. Piper M. E., Baker T. B., Mermelstein R., Collins L. M., Fraser D. L., Jorenby D. E., et al. Recruiting and engaging smokers in treatment in a primary care setting: developing a chronic care model implemented through a modified electronic health record. Transl Behav Med 2013; 3: 253-63.
60. Collins L. M., Dziak J. J., Li R. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psychol Methods 2009; 14: 202-24.
61. Hollis J. F., McAfee T. A., Fellows J. L., Zbikowski S. M., Stark M., Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007; 16: i53-9.
62. Zhu S. H., Stretch V., Balabanis M., Rosbrook B., Sadler G., Pierce J. P. Telephone counseling for smoking cessation: effects of single-session and multiple-session interventions. J Consult Clin Psychol 1996; 64: 202-11.
63. Zhu S. H., Tedeschi G., Anderson C. M., Rosbrook B., Byrd M., Johnson C. E., et al. Telephone counseling as adjuvant treatment for nicotine replacement therapy in a 'real-world' setting. Prev Med 2000; 31: 357-63.
64. Zhu S. H., Anderson C. M., Tedeschi G. J., Rosbrook B., Johnson C. E., Byrd M., et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New Engl J Med 2002; 347: 1087-93.
65. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom K. O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
66. Robinson S. M., Sobell L. C., Sobell M. B., Leo G. I. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav 2014; 28: 154-62.
67. Corporation I. B. M. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corporation; 2013.
68. Heatherton T. F., Kozlowski L. T., Frecker R. C., Rickert W., Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84: 791-9.
69. Hedeker D., Mermelstein R. J., Demirtas H. Analysis of binary outcomes with missing data: missing=smoking, last observation carried forward, and a little multiple imputation. Addiction 2007; 102: 1564-73.
70. Collins L. M., Trail J. B., Kugler K. C., Baker T. B., Piper M. E., Mermelstein R. J. Evaluating individual intervention components: making decisions based on the results of a factorial screening experiment. Transl Behav Med 2014; 4: 238-51.
71. Schnoll R. A., Patterson F., Wileyto E. P., Heitjan D. F., Shields A. E., Asch D. A., et al. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med 2010; 152: 144-51.